Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors

Journal

• Cancer and Metastasis Reviews

  Cancer and Metastasis Reviews 18 (4), 473-481, 1999

  Springer Science and Business Media LLC